Phreesia (NYSE:PHR – Get Free Report) had its target price reduced by equities research analysts at Robert W. Baird from $40.00 to $39.00 in a report issued on Thursday, FlyOnTheWall reports. Robert W. Baird’s target price points to a potential upside of 77.68% from the stock’s previous close.
Other research analysts have also issued research reports about the stock. Canaccord Genuity Group reissued a “buy” rating and issued a $46.00 price target on shares of Phreesia in a research report on Friday, September 1st. KeyCorp decreased their price objective on shares of Phreesia from $45.00 to $40.00 in a research note on Thursday, May 25th. Finally, Stephens reaffirmed an “overweight” rating and set a $37.00 price objective on shares of Phreesia in a research note on Tuesday, August 15th. Two equities research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. According to MarketBeat.com, Phreesia has an average rating of “Moderate Buy” and an average price target of $38.00.
Read Our Latest Stock Analysis on PHR
Phreesia Stock Performance
Phreesia (NYSE:PHR – Get Free Report) last posted its quarterly earnings results on Wednesday, September 6th. The company reported ($0.68) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.71) by $0.03. Phreesia had a negative net margin of 47.75% and a negative return on equity of 52.47%. The firm had revenue of $85.80 million during the quarter, compared to analyst estimates of $85.26 million. During the same quarter in the prior year, the business posted ($0.89) earnings per share. The company’s quarterly revenue was up 26.4% compared to the same quarter last year. Research analysts anticipate that Phreesia will post -2.69 earnings per share for the current fiscal year.
Insider Activity
In other news, SVP Michael J. Davidoff sold 1,075 shares of the stock in a transaction that occurred on Friday, July 21st. The shares were sold at an average price of $31.75, for a total transaction of $34,131.25. Following the sale, the senior vice president now directly owns 93,576 shares of the company’s stock, valued at $2,971,038. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 5.80% of the stock is owned by insiders.
Hedge Funds Weigh In On Phreesia
Hedge funds and other institutional investors have recently bought and sold shares of the business. Acadian Asset Management LLC bought a new position in Phreesia in the first quarter valued at approximately $43,000. Captrust Financial Advisors boosted its stake in Phreesia by 154.6% in the second quarter. Captrust Financial Advisors now owns 1,426 shares of the company’s stock valued at $36,000 after acquiring an additional 866 shares during the last quarter. State of Wyoming raised its holdings in Phreesia by 34.6% in the second quarter. State of Wyoming now owns 1,918 shares of the company’s stock worth $59,000 after purchasing an additional 493 shares during the period. Tower Research Capital LLC TRC raised its holdings in Phreesia by 85.4% in the third quarter. Tower Research Capital LLC TRC now owns 3,137 shares of the company’s stock worth $80,000 after purchasing an additional 1,445 shares during the period. Finally, Bessemer Group Inc. acquired a new stake in Phreesia in the first quarter worth $127,000. 94.37% of the stock is owned by institutional investors.
Phreesia Company Profile
Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. Its Phreesia Platform offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.
Recommended Stories
- Five stocks we like better than Phreesia
- Your Comprehensive Guide to Investing in Bank Stocks
- The Best 5 Small Cap AI Companies to Buy Now
- What is a Stock Market Index and How Do You Use Them?
- Miso Robotics Stock: Is an IPO Coming Soon?
- How to Invest in Renewable Energy
- 3 Stocks to Play the Easing Food Supply Chain
Receive News & Ratings for Phreesia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phreesia and related companies with MarketBeat.com's FREE daily email newsletter.
